Citigroup Inc Hookipa Pharma Inc. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.27 - $15.0 $237 - $2,805	-187 Reduced 71.65%	74 $0
Q2 2022 Aug 10, 2022	SELL	$1.33 - $2.31 $742 - $1,288	-558 Reduced 68.13%	261 $0
Q1 2022 May 12, 2022	SELL	$1.26 - $2.52 $5,227 - $10,455	-4,149 Reduced 83.51%	819 $2,000
Q4 2021 Feb 10, 2022	SELL	$2.33 - $5.94 $23,258 - $59,293	-9,982 Reduced 66.77%	4,968 $12,000
Q3 2021 Nov 10, 2021	BUY	$5.89 - $9.35 $88,055 - $139,782	14,950 New	14,950 $88,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.